About HeartSciences
Radically increasing the clinical value of the ECG through AI-powered technology.
Company Overview
HeartSciences is a medical technology company focused on applying innovative AI-based technology to ECGs to expand and improve ECG clinical utility. Millions of ECGs are performed every week.
Our objective is to improve healthcare by making the ECG a far more valuable screening tool, particularly in frontline or point-of-care clinical settings.
HeartSciences has one of the largest libraries of AI-ECG algorithms and intends to provide these AI-ECG algorithms on a device-agnostic cloud-based solution as well as a low-cost ECG hardware platform.
Working with clinical experts, HeartSciences ensures that all solutions are designed to work within existing clinical care pathways, making it easier for clinicians to use AI-ECG technology to improve their patients' care and lead to better outcomes.
Our Mission
"To enable accurate and affordable solutions for the early detection of heart disease."
Leadership Team
Andrew Simpson
Chairman and CEO
Mark Hilz
Chief Operating Officer
Danielle Watson
Chief Financial Officer
Aaron Peterson
VP Research and Development
Isabella Schmitt
VP Clinical and Regulatory Affairs
Board of Directors
Andrew Simpson
Chairman and CEO
Mark Hilz
Board Member
Brian Szymczak
Board Member
David R. Wells
Board Member
Bruce Bent
Board Member
Scientific Advisory Board
Ready to Transform Your Cardiac Screening?
Request a demo to see how HeartSciences AI-ECG technology can enhance early detection of heart disease in your practice or health system.
Clinical Evidence Review
Walk through our 23 peer-reviewed publications and clinical validation data.
Platform Demonstration
See the MyoVista Insights cloud platform and device integration in action.
Implementation Planning
Discuss integration with your clinical workflows and EHR systems.